Skip to main content
Top
Published in: Rheumatology International 8/2019

01-08-2019 | Polymyositis | Cases with a Message

Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature

Authors: George K. Papadimas, Charalampos Kokkinis, Sophia Xirou, Margarita Chrysanthou, Evangelia Kararizou, Constantinos Papadopoulos

Published in: Rheumatology International | Issue 8/2019

Login to get access

Abstract

Polymyositis with mitochondrial pathology (PM-Mito) is a rare form of idiopathic inflammatory myopathy with no definite diagnostic criteria and similarities to both PM and sporadic inclusion body myositis (s-IBM). The aim of this study is to address the dilemma of whether PM-Mito is a subtype of inflammatory myopathy or represents a disease falling into the spectrum of s-IBM. Herein, we report four female patients diagnosed with PM-Mito, highlighting their rather atypical clinical and histopathological characteristics that seem to indicate a diagnosis away from s-IBM. Muscle weakness was rather proximal and symmetrical and lacked the selective pattern observed in s-IBM. Patients had large-scale deletions in mtDNA, reflecting the mitochondrial component in the pathology of the disease. Conclusively, our study adds to the limited data in the literature on whether PM-Mito is a distinct form of myositis or represents a prodromal stage of s-IBM. Although the latter seems to be supported by a substantial body of evidence, there are, however, important differences, such as the different patterns of muscle weakness, and the good response to treatment observed in some patients. Larger-scale studies are certainly needed to clarify pathogenesis and clinical characteristics of PM-Mito patients, especially in therapeutic and prognostic terms.
Appendix
Available only for authorised users
Literature
1.
go back to reference Amato AA, Greenberg SA (2013) Inflammatory myopathies. Continuum (Minneap Minn) 19(6 Muscle Disease):1615–1633 Amato AA, Greenberg SA (2013) Inflammatory myopathies. Continuum (Minneap Minn) 19(6 Muscle Disease):1615–1633
2.
go back to reference Lundberg IE, de Visser Μ, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14(5):269–278CrossRef Lundberg IE, de Visser Μ, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14(5):269–278CrossRef
3.
go back to reference Blume G, Pestronk A, Frank B, Johns DR (1997) Polymyositis with cytochrome oxidase negative muscle fibers. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain J Neurol 120(1):39–45CrossRef Blume G, Pestronk A, Frank B, Johns DR (1997) Polymyositis with cytochrome oxidase negative muscle fibers. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain J Neurol 120(1):39–45CrossRef
4.
go back to reference Rygiel KA, Miller J, Grady JP, Rocha MC, Taylor RW, Turnbull DM (2015) Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathol Appl Neurobiol 41:288–303CrossRef Rygiel KA, Miller J, Grady JP, Rocha MC, Taylor RW, Turnbull DM (2015) Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathol Appl Neurobiol 41:288–303CrossRef
5.
go back to reference Oldfors A, Moslemi AR, Jonasson L, Ohlsson M, Kollberg G, Lindberg C (2006) Mitochondrial abnormalities in inclusion-body myositis. Neurology 66(1 suppl 1):S49–S55CrossRef Oldfors A, Moslemi AR, Jonasson L, Ohlsson M, Kollberg G, Lindberg C (2006) Mitochondrial abnormalities in inclusion-body myositis. Neurology 66(1 suppl 1):S49–S55CrossRef
6.
go back to reference Chariot P, Ruet E, Authier FJ, Labes D, Poron F, Gherardi R (1996) Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies. Acta Neuropathol 91(5):530–536CrossRef Chariot P, Ruet E, Authier FJ, Labes D, Poron F, Gherardi R (1996) Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies. Acta Neuropathol 91(5):530–536CrossRef
7.
go back to reference Varadhachary AS, Weihl CC, Pestronk A (2010) Mitochondrial pathology in immune and inflammatory myopathies. Curr Opin Rheumatol 22(6):651–657CrossRef Varadhachary AS, Weihl CC, Pestronk A (2010) Mitochondrial pathology in immune and inflammatory myopathies. Curr Opin Rheumatol 22(6):651–657CrossRef
8.
go back to reference Siepmann T, Tesch M, Krause F, Illigens BMW, Stoltenburg Didinger G (2013) Polymyositis with cytochrome C oxidase negative fibers—a pathological and clinical challenge. Ann Diagn Pathol 17(2):183–186CrossRef Siepmann T, Tesch M, Krause F, Illigens BMW, Stoltenburg Didinger G (2013) Polymyositis with cytochrome C oxidase negative fibers—a pathological and clinical challenge. Ann Diagn Pathol 17(2):183–186CrossRef
9.
go back to reference Temiz P, Weihl CC, Pestronk A (2009) Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci 278(1–2):25–29CrossRef Temiz P, Weihl CC, Pestronk A (2009) Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci 278(1–2):25–29CrossRef
10.
go back to reference Hiniker A, Daniels BH, Lee HS, Margeta M (2013) Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies. Acta Neuropathol Commun 1(1):29CrossRef Hiniker A, Daniels BH, Lee HS, Margeta M (2013) Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies. Acta Neuropathol Commun 1(1):29CrossRef
11.
go back to reference Miller S, Dykes D, Polesky HA (1988) simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215CrossRef Miller S, Dykes D, Polesky HA (1988) simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215CrossRef
12.
go back to reference Florence JM, Pandya S, King WM, Robison JD, Baty J, Miller JP, Signore LC (1992) Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne’s muscular dystrophy. Phys Ther 72(2):115–122CrossRef Florence JM, Pandya S, King WM, Robison JD, Baty J, Miller JP, Signore LC (1992) Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne’s muscular dystrophy. Phys Ther 72(2):115–122CrossRef
13.
go back to reference Lindgren U, Roos S, Hedberg Oldfors C, Moslemi AR, Lindberg C, Oldfors Α (2015) Mitochondrial pathology in inclusion body myositis. Neuromuscul Disord 25(4):281–288CrossRef Lindgren U, Roos S, Hedberg Oldfors C, Moslemi AR, Lindberg C, Oldfors Α (2015) Mitochondrial pathology in inclusion body myositis. Neuromuscul Disord 25(4):281–288CrossRef
14.
go back to reference Greenberg SA (2016) Inclusion body myositis. Continuum (Minneap Minn) 22(6, Muscle and Neuromuscular Junction Disorders):1871–1888 Greenberg SA (2016) Inclusion body myositis. Continuum (Minneap Minn) 22(6, Muscle and Neuromuscular Junction Disorders):1871–1888
15.
go back to reference Simon JP, Marie I, Jouen F, Boyer O, Martinet J (2016) Autoimmune myopathies: where do we stand? Front Immunol 7:234CrossRef Simon JP, Marie I, Jouen F, Boyer O, Martinet J (2016) Autoimmune myopathies: where do we stand? Front Immunol 7:234CrossRef
16.
go back to reference Gallay L, Petiot P (2016) Sporadic inclusion-body myositis: recent advances and the state of the art in 2016. Rev Neurol (Paris) 172(10):581–586CrossRef Gallay L, Petiot P (2016) Sporadic inclusion-body myositis: recent advances and the state of the art in 2016. Rev Neurol (Paris) 172(10):581–586CrossRef
17.
go back to reference Mastaglia FL, Needham M (2015) Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. J Clin Neurosci 22(1):6–13CrossRef Mastaglia FL, Needham M (2015) Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. J Clin Neurosci 22(1):6–13CrossRef
18.
go back to reference Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR (2007) Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc 82:441–447CrossRef Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR (2007) Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc 82:441–447CrossRef
19.
go back to reference Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C (1995) Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 54:581–587CrossRef Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C (1995) Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 54:581–587CrossRef
20.
go back to reference Santorelli FM, Sciacco M, Tanji K, Shanske S, Vu TH, Golzi V, Pestronk A (1996) Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol 39(6):789–795CrossRef Santorelli FM, Sciacco M, Tanji K, Shanske S, Vu TH, Golzi V, Pestronk A (1996) Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol 39(6):789–795CrossRef
21.
go back to reference Rygiel KA, Tuppen HA, Grady JP (2016) Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis. Nucleic Acids Res 44:5313–5329CrossRef Rygiel KA, Tuppen HA, Grady JP (2016) Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis. Nucleic Acids Res 44:5313–5329CrossRef
22.
go back to reference Lamperti C, Zeviani M (2009) Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk. Acta Myol 28(1):2–11PubMedPubMedCentral Lamperti C, Zeviani M (2009) Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk. Acta Myol 28(1):2–11PubMedPubMedCentral
23.
go back to reference Moslemi AR, Lindberg C, Oldfors A (1997) Analysis of multiple mitochondrial DNA deletions in inclusion body myositis. Hum Mutat 10(5):381–386CrossRef Moslemi AR, Lindberg C, Oldfors A (1997) Analysis of multiple mitochondrial DNA deletions in inclusion body myositis. Hum Mutat 10(5):381–386CrossRef
24.
go back to reference Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705–713CrossRef Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705–713CrossRef
25.
go back to reference Wallace DC (2010) Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen 51(5):440–450PubMed Wallace DC (2010) Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen 51(5):440–450PubMed
26.
go back to reference Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine 83(5):280–291CrossRef Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine 83(5):280–291CrossRef
27.
go back to reference Fauchais AL, Martel C, Gondran G, Lambert M, Launav D, Jauberteau MO, Hachulla E, Vidal E, Hatron PY (2010) Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 9(9):595–609CrossRef Fauchais AL, Martel C, Gondran G, Lambert M, Launav D, Jauberteau MO, Hachulla E, Vidal E, Hatron PY (2010) Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 9(9):595–609CrossRef
28.
go back to reference Rojana-Udomsart A, Needham M, Luo YB, Fabian V, Walters S, Zilko PJ, Mastaglia FL (2011) The association of sporadic inclusion body myositis and Sjögren’s syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Clin Neurol Neurosurg 113(7):559–563CrossRef Rojana-Udomsart A, Needham M, Luo YB, Fabian V, Walters S, Zilko PJ, Mastaglia FL (2011) The association of sporadic inclusion body myositis and Sjögren’s syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Clin Neurol Neurosurg 113(7):559–563CrossRef
29.
go back to reference Finsterer J, Stöllberger C, Grossegger C, Kroiss A (1999) Hypothyroid myopathy with unusually high serum creatine kinase values. Horm Res 52(4):205–208PubMed Finsterer J, Stöllberger C, Grossegger C, Kroiss A (1999) Hypothyroid myopathy with unusually high serum creatine kinase values. Horm Res 52(4):205–208PubMed
30.
go back to reference Modi G (2000) Cores in hypothyroid myopathy: a clinical, histological and immunofluorescence study. J Neurol Sci 175(1):28–32CrossRef Modi G (2000) Cores in hypothyroid myopathy: a clinical, histological and immunofluorescence study. J Neurol Sci 175(1):28–32CrossRef
31.
go back to reference Brady S, Squier W, Hilton-Jones D (2013) Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. J Neurol Neurosurg Psychiatry 84:1240–1246CrossRef Brady S, Squier W, Hilton-Jones D (2013) Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. J Neurol Neurosurg Psychiatry 84:1240–1246CrossRef
32.
go back to reference Brady S, Squier W, Sewry C, Hanna M, Hilton-Jones D, Holton JL (2014) A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open 4(4):e004552CrossRef Brady S, Squier W, Sewry C, Hanna M, Hilton-Jones D, Holton JL (2014) A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open 4(4):e004552CrossRef
Metadata
Title
Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature
Authors
George K. Papadimas
Charalampos Kokkinis
Sophia Xirou
Margarita Chrysanthou
Evangelia Kararizou
Constantinos Papadopoulos
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04314-8

Other articles of this Issue 8/2019

Rheumatology International 8/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.